Myotubular and Centronuclear Myopathy Patient Registry

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorNewcastle-upon-Tyne Hospitals NHS Trust

About this trial

The Myotubular and Centronuclear Myopathy Patient Registry (also referred to as the 'MTM and CNM Registry') is an international, patient-reported database specific to these conditions.

More details and online registration are available at www.mtmcnmregistry.org.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients with a myotubular myopathy or centronuclear myopathy diagnosis, which has been confirmed via genetic testing or muscle biopsy.

Any carrier females of x-linked myotubular myopathy, especially if they have manifested myotubular myopathy type symptoms.

Any patient who is deceased, but who had a confirmed diagnosis.

Disqualifiers

None

Trial population

Eligible participants from any country. Registration is voluntary, and initiated by participants.

Trial design

Design model

Case-only

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

No trial groups listed

Trial outcomes

Primary outcomes

1

Patient questionnaire

Patient reported clinical diagnosis, genetic mutation, motor function, wheelchair use, respiratory function, ventilation type, chest infection, feeding and heart function, neuromuscular examinations, scoliosis surgery, family history and other registries joined. No scales are collected. Patient genetic report and muscle biopsy report are also uploaded to the registry if available, with details of clinician and where the tests were conducted.

Time frame
12 months

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Newcastle-upon-Tyne Hospitals NHS Trust

Lead sponsor

Myotubular Trust

Collaborator

Muscular Dystrophy UK

Collaborator

Astellas Gene Therapies

Collaborator

Astellas Pharma Inc

Collaborator